Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butorphanol tartrate nasal spray for pain self-management in multiple myeloma
ChiCTR2000034792Phase 4Recruiting
- Sponsor
- Affiliated Hospital of Southwest Medical University
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of butorphanol in multiple myeloma (MM) (2 arms), sponsored by Affiliated Hospital of Southwest Medical University. Primary endpoint: pain score. Started Jul 2020; status: recruiting.
02
Drugs
butorphanol
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on ChiCTR2000034792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034792.